Praxis Precision Medicines, Inc. · NASDAQ:PRAX
Soleus Capital Master Fund, L.P. reported a 5.00% stake in Praxis Precision Medicines, Inc. (Schedule 13G)
Event Mar 18, 2025 · Filed Mar 19, 2025
Soleus Capital Master Fund, L.P. reported a 5.00% stake in Praxis Precision Medicines, Inc., 1,017,740 shares, as a passive investor on Mar 18, 2025. Filed Mar 19, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 1,017,740
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 5.00% | 1,017,740 |
| Soleus Capital, LLC | 5.00% | 1,017,740 |
| Soleus Capital Group, LLC | 5.00% | 1,017,740 |
| Soleus Capital Management, L.P. | 5.00% | 1,017,740 |
| Soleus GP, LLC | 5.00% | 1,017,740 |
| Guy Levy | 5.00% | 1,017,740 |
Source
Related
- Praxis Precision Medicines, Inc.
- Soleus Capital Master Fund, L.P.
- Praxis Precision Medicines, Inc. shareholders
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 5, 2025
- Schedule 13G/A · Orbis Investment Management LTD · Aug 14, 2026
- Form 4 · Souza Marcio · Jul 8, 2026
- Form 4 · DeSimone Jill · Jun 26, 2026
- Form 4 · Arbuckle Stuart A · Jun 12, 2026
- Form 4 · Chodakewitz Jeffrey · Jun 12, 2026